Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Calorie restriction & fasting
Research brief

Liver oxylipin profiles in calorie-restricted versus ad libitum mice across aging

In mice, lifelong calorie restriction blunted a mid-life shift toward pro-inflammatory liver oxylipins, preserved EPA-derived epoxy-fatty acids and induced the redox enzyme CYB5R3; these changes coincided with less liver lipid accumulation and a more favorable systemic metabolic profile. [1]

Automatic summary · not editorially reviewed

The key findings

  1. In ad libitum-fed mice, about 9 months appeared as an inflection point toward a pro-inflammatory liver oxylipin state. [1]

  2. Lifelong calorie restriction preserved EPA-derived epoxy-fatty acids and induced the redox enzyme CYB5R3. [1]

  3. The authors nominate CYB5R3-associated redox regulation as a hypothesis for future mechanistic investigation. [1]

The source at a glance

Study type / format
Abstract of a preclinical mouse study with age-stratified targeted oxylipin profiling.
Population / context
Livers from mice fed ad libitum or with lifelong calorie restriction, profiled across adulthood and aging.
Summary based on
Study abstract
Original publication
September 18, 2026

Liver lipid mediators in AL versus CR mice

The abstract describes targeted profiling of oxylipins, which are lipid mediators, in livers of mice fed ad libitum (AL) or with lifelong calorie restriction (CR), sampled across adulthood and aging. In AL-fed mice, about 9 months appeared as an inflection point: oxylipin networks shifted toward a pro-inflammatory state, with transient rises in PGE₂, 11-keto-TXB₂, 20-HETE and 5-oxo-ETE and loss of pro-resolving mediators. Later life showed depletion of CYP-derived epoxides and accumulation of soluble epoxide hydrolase-generated diols.

Supporting source [1]

CR blunted mid-life surge and preserved epoxides

Lifelong CR dynamically reprogrammed these trajectories: it blunted the mid-life inflammatory surges, preserved EPA-derived epoxy-fatty acids such as EpETEs, and induced the redox enzyme CYB5R3. The authors suggest CYB5R3 may sustain CYP epoxygenase activity and epoxide output despite reduced enzyme abundance. These oxylipin changes coincided with reduced hepatic lipid accumulation and a more favorable systemic metabolic profile in CR mice.

Supporting source [1]

Hypothesis for future mechanistic work, not proven cause

The authors frame their findings as identifying age- and diet-associated remodeling of the hepatic COX/LOX/CYP oxylipin network, especially the epoxide-diol profile. They nominate CYB5R3-associated redox regulation as a hypothesis for future mechanistic investigation, not as an established mechanism. The described coincidences between oxylipin changes and metabolic measures are associations in mice, not evidence of cause or of human lifespan benefit.

Supporting source [1]

How to interpret this

This is an abstract; the full text was not reviewed. The work is in mice, and the CYB5R3 link is presented as a hypothesis, not a demonstrated mechanism. The metabolic findings are described as coinciding with oxylipin changes, so they are associations, not proof of cause or of human benefit.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Lifelong caloric restriction reshapes age-related hepatic oxylipin profiles and is associated with a CYB5R3-linked epoxide-diol signature.

Wei L, Sun D, Huang Y, Ouyang X, Zheng J, Yu Y, Han C, Yang Y, Hong J, Zheng Y. · europepmc.org · September 18, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    ~9 months emerged as an inflection point
  2. Finding 2 ↑

    preserving EPA-derived epoxy-fatty acids
  3. Finding 3 ↑

    a hypothesis for future mechanistic investigation

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…